Your session is about to expire
← Back to Search
Device
CycloPen Cyclodialysis System for Open-Angle Glaucoma (CREST Trial)
N/A
Waitlist Available
Research Sponsored by Iantrek, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months postoperative
Awards & highlights
No Placebo-Only Group
Summary
This trial involves adults with open angle glaucoma who had surgery to lower eye pressure. The study will follow these patients for two years to collect data on eye pressure, medication use, and any side effects.
Eligible Conditions
- Open-Angle Glaucoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months postoperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months postoperative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percent of eyes with intraocular pressure (IOP) reduction ≥ 20% in comparison with baseline
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: CycloPen Cyclodialysis System in standalone surgeryExperimental Treatment1 Intervention
Ophthalmic surgical intervention with the CycloPen Cyclodialysis System
Group II: CycloPen Cyclodialysis System in conjunction with cataract surgeryExperimental Treatment1 Intervention
Ophthalmic surgical intervention with the CycloPen Cyclodialysis System in conjunction with cataract surgery
Find a Location
Who is running the clinical trial?
Iantrek, Inc.Lead Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
Gautam Kamthan, MDStudy DirectorIantrek, Inc.
Share this study with friends
Copy Link
Messenger